Hidden treasures of University of Arizona Libraries Oct. 19, 2022 The UArizona Health Sciences Library, located in the College of Medicine – Tucson, is among the many libraries to frequent on campus. Arizona Daily Wildcat
Melatonin can be a nightmare if used incorrectly, experts say Oct. 19, 2022 Melatonin supplements are designed to mimic the effects of the hormone, boosting its levels within the body to induce sleep. United Press International
Certain class of diabetes meds could cut dementia risk Oct. 19, 2022 Xin Tang, a student in the Mel and Enid Zuckerman College of Public Health, is the first author on a paper that found that in patients with Type 2 diabetes, thiazolidinedione monotherapy is associated with reduced dementia risk and sulfonylurea monotherapy is associated with an increased risk compared with metformin monotherapy. HealthDay
How Mentorship Makes Research Happen Oct. 19, 2022 Amanda Wilson, PhD, reflects on how guidance from experienced public health researchers helped her navigate roadblocks in her work to improve cleaning workers’ respiratory health. Read more Image
Drug meant to prevent premature births should be removed from market, FDA panel says Oct. 19, 2022 A federal advisory panel voted Wednesday to recommend that the only approved drug to prevent premature birth be removed from pharmacy shelves because studies have shown it does not work. Los Angeles Times
Test News Title Oct. 19, 2022 Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Habitant morbi tristique senectus et netus. Rutrum tellus pellentesque eu tincidunt tortor aliquam nulla facilisi cras. Read more Image
UArizona Arthritis Center Awarded $3.4M to Study Rapid Knee Deterioration Oct. 18, 2022 Dr. C. Kent Kwoh will lead a study that seeks to develop methods to predict who will experience rapid knee deterioration or need knee replacements in the future. Read more Image
Vonoprazan promising for erosive esophagitis Oct. 18, 2022 The oral potassium-competitive acid blocker vonoprazan was noninferior and superior to the proton pump inhibitor lansoprazole for erosive esophagitis, according to results of the phase 3 trial. Medscape
UArizona Arthritis Center awarded $3.4M to study rapid knee deterioration Oct. 18, 2022 Researchers at the UArizona Arthritis Center are undertaking a study that seeks to identify determinants of rapid knee deterioration thanks to a $3.4 million grant from the National Institutes of Health. KVOA-TV (Tucson, AZ)